AC Immune SA (ACIU)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
250,556,000
EV to revenue ratio (TTM)
9.12
EV to ebitda
-0.764
Financial Performance
Revenue (TTM)
17,509,000
Gross profit (TTM)
-28,405,000
EBITDA
-42,479,000
Profitability
Operating margin (TTM)
7.89%
Profit margin
-246.50%
Return on assets (TTM)
-16.00%
Return on equity (TTM)
-78.50%
Per Share Metrics
Revenue per share (TTM)
0.17
EPS
-0.52
Diluted EPS (TTM)
-0.52
Book value
0.43
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
16.64
PEG ratio
0
Price to sales ratio (TTM)
14.31
Price to book ratio (TTM)
6.57
Growth
Quarterly earnings growth (YoY)
1,057.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.595